Schrödinger, Inc. (SDGR)

Nasdaq Health Care Health Care Services S&P SmallCap 600

$29.82

+1.05 (+3.65%)

Close of Nov 06, 2026 · end-of-day data

Source: Schrödinger, Inc.'s 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$85.54M	$108.09M	$137.93M	$180.96M	$216.67M	$207.54M	$255.87M
Cost of revenue	$36.45M	$44.62M	$72.31M	$79.93M	$75.97M	$75.46M	$113.25M
Gross profit	$49.09M	$63.47M	$65.62M	$101.02M	$140.69M	$132.08M	$142.61M
Research & development	$39.40M	$64.69M	$90.90M	$126.37M	$181.77M	$201.78M	$173.14M
Operating income	-$38.72M	-$60.92M	-$111.44M	-$146.82M	-$177.45M	-$209.30M	-$166.90M
Pre-tax income	-$25.97M	-$26.29M	-$100.81M	-$149.12M	$42.92M	-$185.71M	-$102.33M
Income tax	-$291.00K	$345.00K	$411.00K	$63.00K	$2.20M	$1.41M	$939.00K
Net income	-$24.57M	-$24.46M	-$100.39M	-$149.19M	$40.72M	-$187.12M	-$103.27M
EBITDA	-$35.08M	-$57.26M	-$108.60M	-$142.47M	-$171.90M	-$203.14M	-$160.87M
EPS (basic)	$-4.09	$-0.41	$-1.42	$-2.10	$0.57	$-2.57	$-1.41
EPS (diluted)	$-4.09	$-0.41	$-1.42	$-2.10	$0.54	$-2.57	$-1.41
Diluted shares	6.00M	60.02M	70.59M	71.17M	74.99M	72.67M	73.44M
Gross margin	57.4%	58.7%	47.6%	55.8%	64.9%	63.6%	55.7%
Operating margin	-45.3%	-56.4%	-80.8%	-81.1%	-81.9%	-100.8%	-65.2%
Net margin	-28.7%	-22.6%	-72.8%	-82.4%	18.8%	-90.2%	-40.4%

Balance sheet

fiscal years · USD

Fiscal year	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$25.99M	$202.30M	$120.27M	$90.47M	$155.31M	$147.33M	$230.52M
Short-term investments	$59.84M	$440.39M	$456.21M	$360.61M	$307.69M	$204.80M	$164.95M
Receivables	$18.68M	$31.42M	$31.74M	$55.95M	$65.99M	$235.69M	$83.04M
Total current assets	$118.54M	$682.98M	$625.06M	$533.99M	$567.80M	$634.99M	$519.26M
Goodwill	—	—	$0	$4.79M	$4.79M	$4.79M	$4.79M
Total assets	$155.27M	$746.26M	$756.49M	$688.59M	$802.96M	$823.23M	$726.16M
Total current liabilities	$45.02M	$73.20M	$91.21M	$108.80M	$133.67M	$191.75M	$189.14M
Total liabilities	$57.01M	$122.24M	$199.40M	$240.68M	$254.40M	$401.78M	$362.11M
Shareholders' equity	-$93.36M	$624.01M	$557.07M	$447.89M	$548.56M	$421.44M	$364.05M

Cash flow

fiscal years · USD

Fiscal year	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$26.06M	$16.76M	-$70.67M	-$119.68M	-$136.73M	-$157.37M	$13.90M
Capital expenditures	$1.84M	$2.54M	$7.17M	$8.01M	$13.40M	$7.31M	$1.44M
Free cash flow	-$27.89M	$14.22M	-$77.84M	-$127.70M	-$150.14M	-$164.68M	$12.46M
Investing cash flow	-$53.85M	-$381.72M	-$16.81M	$90.02M	$193.03M	$148.84M	$57.90M
Financing cash flow	$28.68M	$541.27M	$7.95M	$2.11M	$9.05M	$10.12M	$2.93M
Stock-based compensation	$2.19M	$10.54M	$26.49M	$39.63M	$47.84M	$49.90M	$43.00M
Depreciation & amortization	$3.64M	$3.66M	$2.85M	$4.34M	$5.55M	$6.16M	$6.02M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$74.13M	$36.60M	$47.33M	$35.29M	$88.32M	$59.55M	$54.76M	$54.32M	$87.23M	$58.59M	$58.89M	$64.49M
Cost of revenue	$16.58M	$17.71M	$16.00M	$17.56M	$24.19M	$28.43M	$28.60M	$26.29M	$29.94M	$29.04M	$26.46M	$26.24M
Gross profit	$57.55M	$18.89M	$31.34M	$17.73M	$64.13M	$31.12M	$26.16M	$28.04M	$57.29M	$29.55M	$32.43M	$38.25M
Research & development	$51.49M	$50.61M	$50.84M	$50.98M	$49.36M	$45.84M	$43.14M	$42.76M	$41.40M	$43.82M	$41.00M	$34.09M
Operating income	-$29.62M	-$67.43M	-$52.73M	-$68.42M	-$20.71M	-$50.89M	-$52.90M	-$45.95M	-$17.16M	-$48.79M	-$41.55M	-$26.13M
Pre-tax income	-$31.51M	-$54.27M	-$53.96M	-$38.23M	-$39.25M	-$59.78M	-$42.89M	-$32.63M	$32.97M	-$59.62M	$7.35M	-$37.55M
Income tax	-$842.00K	$456.00K	$83.00K	-$90.00K	$963.00K	$28.00K	$287.00K	$162.00K	$462.00K	$408.00K	$1.37M	$156.00K
Net income	-$30.67M	-$54.72M	-$54.05M	-$38.14M	-$40.22M	-$59.81M	-$43.17M	-$32.80M	$32.51M	-$60.03M	$5.97M	-$37.71M
EBITDA	-$28.27M	-$66.00M	-$51.33M	-$66.86M	-$18.95M	-$49.30M	-$51.37M	-$44.48M	-$15.72M	-$47.32M	-$40.06M	-$24.67M
EPS (basic)	$-0.43	$-0.76	$-0.74	$-0.52	$-0.55	$-0.82	$-0.59	$-0.45	$0.44	$-0.81	$0.08	$-0.50
EPS (diluted)	$-0.41	$-0.76	$-0.74	$-0.52	$-0.55	$-0.82	$-0.59	$-0.45	$0.44	$-0.81	$0.08	$-0.50
Diluted shares	20.02K	72.29M	72.71M	72.81M	64.26K	73.06M	73.43M	73.61M	75.05K	73.99M	75.77M	74.87M
Gross margin	77.6%	51.6%	66.2%	50.2%	72.6%	52.3%	47.8%	51.6%	65.7%	50.4%	55.1%	59.3%
Operating margin	-40.0%	-184.3%	-111.4%	-193.9%	-23.5%	-85.5%	-96.6%	-84.6%	-19.7%	-83.3%	-70.6%	-40.5%
Net margin	-41.4%	-149.5%	-114.2%	-108.1%	-45.5%	-100.4%	-78.8%	-60.4%	37.3%	-102.5%	10.1%	-58.5%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$155.31M	$130.24M	$108.11M	$160.42M	$147.33M	$326.00M	$219.90M	$172.12M	$230.52M	$260.25M	$287.85M	$246.98M
Short-term investments	$307.69M	$300.84M	$269.18M	$228.26M	$204.80M	$174.30M	$230.28M	$219.11M	$164.95M	$138.70M	$125.89M	$119.38M
Receivables	$65.99M	$19.84M	$11.85M	$13.28M	$235.69M	$20.35M	$10.07M	$29.38M	$83.04M	$27.25M	$21.39M	$48.36M
Total current assets	$567.80M	$493.69M	$449.18M	$456.40M	$634.99M	$570.94M	$514.00M	$471.72M	$519.26M	$463.96M	$470.48M	$456.54M
Goodwill	$4.79M	$4.79M	$4.79M	$4.79M	$4.79M	$4.79M	$4.79M	$4.79M	$4.79M	$4.79M	$4.79M	$4.79M
Total assets	$802.96M	$737.76M	$688.37M	$669.30M	$823.23M	$743.03M	$688.24M	$653.66M	$726.16M	$634.19M	$640.39M	$611.94M
Total current liabilities	$133.67M	$106.51M	$99.76M	$111.12M	$191.75M	$165.47M	$155.77M	$145.11M	$189.14M	$169.54M	$173.84M	$166.29M
Total liabilities	$254.40M	$224.06M	$214.39M	$219.87M	$401.78M	$369.53M	$345.37M	$332.31M	$362.11M	$320.64M	$311.44M	$310.11M
Shareholders' equity	$548.56M	$513.71M	$473.98M	$449.43M	$421.44M	$373.50M	$342.87M	$321.35M	$364.05M	$313.55M	$328.96M	$301.83M

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	-$37.26M	-$39.28M	-$53.72M	-$33.26M	-$31.11M	$144.06M	-$52.20M	-$61.87M	-$16.09M	-$14.83M	-$34.07M	-$47.58M
Capital expenditures	$2.48M	$4.09M	$1.00M	$1.34M	$873.00K	$596.00K	$314.00K	$491.00K	$41.00K	$2.51M	$362.00K	$1.29M
Free cash flow	-$39.73M	-$43.37M	-$54.72M	-$34.60M	-$31.99M	$143.47M	-$52.51M	-$62.36M	-$16.13M	-$17.34M	-$34.43M	-$48.87M
Investing cash flow	-$59.61M	$5.08M	$29.58M	$90.70M	$23.48M	$30.63M	-$55.60M	$11.46M	$71.41M	$44.60M	$58.62M	$5.94M
Financing cash flow	$2.33M	$8.01M	$1.61M	$392.00K	$119.00K	$409.00K	$2.02M	$307.00K	$197.00K	$569.00K	$650.00K	$2.72M
Stock-based compensation	$12.53M	$12.22M	$12.81M	$12.40M	$12.48M	$11.57M	$10.63M	$10.85M	$9.95M	$9.07M	$8.79M	$7.93M
Depreciation & amortization	$1.35M	$1.44M	$1.40M	$1.56M	$1.76M	$1.59M	$1.53M	$1.47M	$1.44M	$1.48M	$1.49M	$1.46M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.